Inventor
Arlindo L. Castelhano
Inventor
New City, NY, US
Overview
Patents· 47 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes16%
C07KPeptides7%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
C04BLime, magnesia1%
C07BGeneral methods of organic chemistry1%
C40BCombinatorial chemistry1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
8,557,814'mTOR inhibitor salt forms'20137,829,717'(Arylamidoaryl)squaramide compounds'20107,767,673'N-substituted imidazopyridine c-Kit inhibitors'20107,662,844'Naphthylene derivatives as cytochrome P450 inhibitors'20107,645,754'Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use'20107,598,252'Compounds specific to adenosine A, receptors and uses thereof'20097,521,448'N-substituted benzimidazolyl c-Kit inhibitors'20097,504,407'Compounds specific to adenosine A1 and A3 receptors and uses thereof'20097,501,407'Pyrimidine A2B selective antagonist compounds, their synthesis and use'20097,485,658'N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors'20097,442,709'N3-substituted imidazopyridine c-Kit inhibitors'20087,439,256'(Arylamidoaryl) cyanoguanidine compounds'20087,429,574'4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use'20087,262,196'Tri(cyclo) substituted amide glucokinase activator compounds'20077,160,890'Compounds specific to adenosine A3 receptor and uses thereof'20077,064,122'Pancreatic lipase inhibitor compounds, their synthesis and use'20066,949,563'(2-carboxamido)(3-amino)thiophene compounds'20056,916,804'Pyrimidine A2b selective antagonist compounds, their synthesis and use'20056,878,716'Compounds specific to adenosine A1 receptor and uses thereof'20056,800,633'Pyrrolo2,3dpyrimidine compositions and their use'20046,686,366'Compounds specific to adenosine A3 receptor and uses thereof'20046,680,322'Compounds specific to adenosine A1 receptors and uses thereof'20046,680,324'Compounds specific to adenosine A1 receptors and uses thereof'20046,673,802'Compounds specific to adenosine A3 receptor and uses thereof'20046,664,252'4-aminopyrrolo2,3-dpyrimidine compounds specific to adenosine A2a receptor and uses thereof'20036,638,941'Conformationallly constrained peptidomimetics as -turn templates and modulators of SH3 domains'20036,495,699'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'20026,465,495'Preparation of pyridone-based phosphotyrosine mimetics and uses thereof'20026,376,506'Sulfamide-metalloprotease inhibitors'20026,376,667'Solid phase synthesis of heterocycles'20026,306,892'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'2001H0001992'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses'20016,174,915'Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses'20016,143,744'Sulfamide-metalloprotease inhibitors'20006,130,220'Sulfamide-metalloprotease inhibitors'20006,037,340'Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds'20006,037,472'Matrix metalloprotease inhibitors'20006,013,792'Matrix metalloprotease inhibitors'20006,008,243'Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use'19995,998,412'Sulfamide-metalloprotease inhibitors'19995,932,595'Matrix metalloprotease inhibitors'19995,773,428'Matrix metalloprotease inhibitors'19984,970,297'Transglutaminase inhibitors'19904,929,630'Transglutaminase inhibitors'19904,912,120'3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors'19904,668,703'.gamma.-allenyl-.gamma.-aminobutyric acids'19874,661,510'.alpha.-allenic-.alpha.-amino acids as enzyme inhibitors'1987Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1987–2001Patents assigned to SYNTEX INC (15)· patent assignee history
1987–1990Based in Mississauga, CA· patent location history
1998–2013Based in New City, NY, US· patent location history
1999–2002Patents assigned to AGOURON PHARMA (10)· patent assignee history
1999Based in New York, NY, US· patent location history
2000Based in Pleasanton, CA, US· patent location history
2002–2010Patents assigned to OSI PHARM INC (24)· patent assignee history
2005–2008Patents assigned to LI AN-HU (2)· patent assignee history
2005Patents assigned to AHMED SALEH (1)· patent assignee history
2008–2010Based in Farmingdale, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OSI PHARM INC | 24 | 2002–2010 |
| SYNTEX INC | 15 | 1987–2001 |
| AGOURON PHARMA | 10 | 1999–2002 |
| LI AN-HU | 2 | 2005–2008 |
| AHMED SALEH | 1 | 2005 |
Locations
| Location | Patents | Span |
|---|---|---|
| New City, New York, US | 35 | 1998–2013 |
| Mississauga, CA | 5 | 1987–1990 |
| Farmingdale, New York, US | 4 | 2008–2010 |
| Pleasanton, California, US | 2 | 2000 |
| New York, New York, US | 1 | 1999 |